TNFRSF1B and esophageal squamous cell carcinoma: In this study, it was demonstrated that the TNFRSF1B A1466G genotype was a predictive factor of clinical response to treatment with a definitive 5-FU/CDDP-based chemoradiotherapy in Japanese ESCC patients.